PrEP adherence among trans women in Brazil-access needed for this key population

Lancet HIV. 2016 May;3(5):e200. doi: 10.1016/S2352-3018(16)30022-4.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-HIV Agents
  • Brazil
  • Female
  • HIV Infections*
  • Humans
  • Medication Adherence
  • Pre-Exposure Prophylaxis*

Substances

  • Anti-HIV Agents